OSTEOCIS

This brand name is authorized in France, Hong Kong SAR China, Ireland, Malta, Spain, UK.

Active ingredients

The drug OSTEOCIS contains one active pharmaceutical ingredient (API):

1	Technetium ⁹⁹ᵐTc oxidronic acid UNII H852YK87WP - OXIDRONATE DISODIUM
	Technetium ⁹⁹ᵐTc oxidronic acid is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. Technetium ⁹⁹ᵐTc oxidronic acid is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget’s disease, arthritic disease, osteomyelitis, and fractures.
	Read more about Technetium ⁹⁹ᵐTc oxidronic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OSTEOCIS Kit for radiopharmaceutical preparation	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09BA01	Technetium (99mTc) oxidronic acid	V Various → V09 Diagnostic radiopharmaceuticals → V09B Skeleton → V09BA Technetium (99mTc) compounds
Discover more medicines within V09BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	76639
FR	Base de données publique des médicaments	63521034
GB	Medicines & Healthcare Products Regulatory Agency	394723
HK	Department of Health Drug Office	43123
MT	Medicines Authority	AA826/00701